Delivery Order SPE2D021DA002-SPE2D325F401Q
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, for HAVRIX 720 Unit/0.5 ML syringes valued at $2,168.80. This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 28, 2025, with performance to be completed at the awardee's Park Ridge, Illinois location. HAVRIX is a...
- This federal contract award, valued at $1,772.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,492.88, is for the delivery of Hepatitis A inactivated vaccine. This order is part of a larger, single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,924.48 firm fixed-price delivery order is for the supply of HAVRIX 1440 UN 1ML 10S medical products. The award is not associated with a set-aside program and has an ultimate completion date of June 20, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,105.90 firm fixed-price delivery order (SPE2DP18F0330) is for the provision of hepatitis A vaccine. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,220.04, is a firm fixed-price purchase order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) for the supply of hepatitis A virus vaccine. The contract has an ultimate completion date of July 7, 2023 and was awarded on June 22, 2023. DMS Pharmaceutical Group holds a significant indefinite delivery contract...
- The Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order for $1,122.98 to supply hepatitis A inactivated vaccines in support of military treatment facilities. DMS Pharmaceutical Group, a woman-owned small business located in Park Ridge, Illinois, will deliver the vaccines to the place of performance by January 31, 2018 under the terms of this unrestricted award. DMS Pharmaceutical Group holds an indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,602.92 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of TWINRIX VACCINE SYRINGE and does not have a set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price purchase order valued at $1,731.12 for Hepatitis A Virus V on August 11, 2025, with an ultimate completion date of August 26, 2025. The contract was funded by the Medical Supply Chain, a Defense agency component, with performance to be executed in Park Ridge, Illinois. This award carries no set-aside designation and represents a delivery order...
- The Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order for $1,105.90 to supply hepatitis A inactivated vaccine under contract number 8504751168. DMS Pharmaceutical Group, a woman-owned small business located in Park Ridge, Illinois, is the prime contractor. Performance will take place at the contractor's facility and delivery is required by October 2, 2017. No set-aside designation was used for this award. DMS Pharmaceutical...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F401QDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,268.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 10, 2025. The delivery order calls for 1,440 units per milliliter of Havrix, a hepatitis A vaccine, to be delivered by September 15, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which holds a ceiling value of $499,999,999 and remains valid through November 2026. The contract was awarded without set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to military and federal healthcare facilities nationwide. The company's extensive portfolio of delivery orders through its DLA IDC enables the agency to procure a wide range of pharmaceutical products in support of medical supply needs across Department of Defense healthcare sites globally. This particular delivery order for Havrix vaccine represents one of numerous pharmaceutical product acquisitions made through this comprehensive supply contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/10/25 |